1-3 of 3
Hanne Oestergaard Larsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD34+ SSC lo ALDH br – a New Marker for Improved Characterization of Poor Myeloid Regeneration in the Autologous Hematopoietic Transplantation Setting?,

Katrine Nielsen, Lea Bjerre, PhD, BSc, MSc,, Hanne Oestergaard Larsen, PhD, MSc,, Peter Hokland, Sr., M.D., D., Med., Sci., Anne Stidsholt Roug, MD
Journal: Blood
Blood (2011) 118 (21): 4007.
https://doi.org/10.1182/blood.V118.21.4007.4007
Published: 2011
Journal Articles

Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?

Anne Stidsholt Roug, MD, Hanne Oestergaard Larsen, PhD, MSc,, Hans Beier Ommen, MD, PhD, Peter Hokland, MD, DMSC
Journal: Blood
Blood (2011) 118 (21): 1447.
https://doi.org/10.1182/blood.V118.21.1447.1447
Published: 2011
Journal Articles

Flow Cytometric Detection of Minimal Residual Disease In Acute Myeloid Leukemia – the Addition of hMICL and CD123 Add to Sensitivity and Applicability

Anne Stidsholt Roug, MD, Jan A. Nolta, PhD, Hanne Oestergaard Larsen, Claus Sondergaard, Ph.D, Peter Hokland, MD, DMSC
Journal: Blood
Blood (2010) 116 (21): 2719.
https://doi.org/10.1182/blood.V116.21.2719.2719
Published: 2010